ArticleBiomarker research2023

SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.

Manuela Mancini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.